New cord blood transplant could help bone marrow disease patients

NCT ID NCT03173937

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 19 times

Summary

This study tests a new way to do stem cell transplants for people with severe aplastic anemia or a related bone marrow disease called MDS. It combines stem cells from a family member with specially grown cord blood cells from an unrelated donor to help the new cells grow faster and safer. Participants will receive chemotherapy and radiation before the transplant and will be followed for 5 years. The goal is to see if this approach improves transplant success and reduces complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME (MDS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.